Swedish Pharma Stock News

OM:VIMIAN
OM:VIMIANMedical Equipment

Vimian Group Q4 EPS Surge Tests Skeptical Narratives On Earnings Durability

Vimian Group (OM:VIMIAN) FY 2025 Earnings Snapshot Vimian Group (OM:VIMIAN) has just closed FY 2025 with Q4 revenue of €110 million and basic EPS of €0.23, setting the tone for a year where trailing twelve month revenue reached €428.3 million and EPS came in at €0.06. Over recent quarters, the company has seen revenue move from €104.3 million in Q2 2025 to €107.5 million in Q1 2025 and €104.3 million in Q3 2025. Quarterly EPS ranged from €0.01 to €0.02 before stepping up to €0.23 in Q4,...
OM:LIME
OM:LIMESoftware

Lime Technologies (OM:LIME) Net Margin Expansion Reinforces Bullish SaaS Narrative

Lime Technologies (OM:LIME) has wrapped up FY 2025 with fourth quarter revenue of SEK 201.1 million and basic EPS of SEK 2.41, giving investors a fresh data point on both top line scale and per share profitability. The company has seen quarterly revenue move from SEK 185.3 million in Q4 2024 to SEK 201.1 million in Q4 2025, while basic EPS over the same quarters shifted from SEK 1.82 to SEK 2.41. This sits alongside trailing twelve month EPS of SEK 8.40 on revenue of SEK 747.4 million and...
OM:INSTAL
OM:INSTALConstruction

Instalco (OM:INSTAL) Q4 Margin Uptick To 2.8% Tests Bullish Recovery Narrative

Instalco (OM:INSTAL) FY 2025 headline numbers set the tone Instalco (OM:INSTAL) has wrapped up FY 2025 with fourth quarter revenue of SEK3.8b and basic EPS of SEK0.49, putting concrete numbers around the company’s latest trading update. The company has seen quarterly revenue range from SEK3.0b to SEK3.8b through 2025, while basic EPS has moved between SEK0.19 and SEK0.49. This gives investors a clear view of how the top line and per share earnings have tracked through the year. With trailing...
OM:CRAD B
OM:CRAD BMedical Equipment

C Rad (OM:CRAD B) Margin Collapse To 2.4% Challenges High P E Narrative

How C-Rad (OM:CRAD B) Finished FY 2025 C-Rad (OM:CRAD B) closed out FY 2025 with fourth quarter revenue of 105.8 million SEK and EPS of 0.05 SEK, capping a year where trailing 12 month revenue came in at 441.9 million SEK and EPS at 0.31 SEK. Over recent periods the company has seen quarterly revenue move between 100.1 million SEK and 121.5 million SEK, while EPS has ranged from a loss of 0.24 SEK in early 2025 to 0.43 SEK in late 2024. This sets the scene for investors to weigh forecast...